Bill S 5665 establishes a doula awareness and education program within the Department of Health. This program directs the department to inform the public and healthcare providers about doulas and their benefits throughout pregnancy, delivery, and birth. The Department of Health will produce and distribute educational materials, making them available to healthcare providers for patients. These materials and the department's website will include information on doulas' role in potentially reducing mortality rates for pregnant individuals, specifically highlighting increased risks for Black pregnant individuals. The department is also required to periodically review relevant data and report on the program's implementation every three years.
Establishes maximum contaminant levels in drinking water for certain per- and polyfluoroalkyl substances (PFAS); sets such levels at no higher than 4 parts per trillion (ppt) for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) and no higher than 10 parts per trillion (ppt) for perfluorononanoic acid (PFNA), perfluorohexane sulfonate (PFHxS), and hexafluoropropylene oxide dimer acid (HFPO-DA).
This bill requires New York's Department of Health to create and maintain a dedicated menopause information webpage on its website within 180 days. The webpage must cover key topics including the stages of menopause (perimenopause, menopause, and postmenopause), treatment and management options, and associated symptoms and health complications. It directly affects residents seeking accessible, official health information about menopause. The mandate focuses on providing factual, standardized resources to the public, with no additional funding or enforcement mechanisms specified.
This bill mandates a state study to examine how hospitals and birthing centers integrate doula care into maternal health services. It requires the health department to identify existing "doula-friendly" facilities, analyze successful programs in New York and other states, and develop recommendations for standardized practices - such as visitor status for doulas, inclusion in birth processes, and data collection. The study will report findings and best practices to the governor and legislature by December 2027. This bill directly affects healthcare facilities, doulas, and maternal health systems by laying groundwork for potential future policy changes, but does not create new laws or funding.
Defines mental health practitioners with diagnostic authority for the purposes of providing services under the workers' compensation law; includes such practitioners as providers.
Senate Bill 4692 requires all private colleges and universities in the state to provide menstrual products. These products must be made available in the restrooms of their school buildings. The bill specifies that these items must be offered at no charge to students. This legislation directly affects private higher education institutions, which must supply the products, and benefits their students by ensuring free access to them.
Provides for enrollment of eligible incarcerated persons in the medical assistance for needy persons program; provides for enrollment of incarcerated individuals in other medical assistance programs, where eligible.
This bill requires large group health insurance plans in New York to cover acupuncture services when prescribed by qualified healthcare providers (as defined under Education Law §8211). It applies to plans covering physician office services or comprehensive medical coverage, mandating coverage for acupuncture treatments but allowing reasonable cost-sharing like deductibles or co-pays. The law does not require full coverage without cost-sharing, only that plans include acupuncture as a covered service under specified conditions. It affects insurers offering large group plans and patients relying on such coverage for acupuncture treatments. The bill takes effect 90 days after enactment for new or renewed policies.
This bill amends New York's insurance law to require health insurers to cover image-guided breast biopsies as part of mandatory breast cancer screening. It directly affects patients seeking breast cancer detection and insurers who must provide this coverage when recommended by a physician following nationally recognized clinical guidelines. The key change adds "image-guided breast biopsies" to the list of covered screening and diagnostic imaging procedures, alongside mammograms and ultrasounds. Coverage applies only when the procedure is recommended by a physician and aligns with evidence-based clinical guidelines. The requirement takes effect January 1, 2026, for new or renewed insurance policies.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.